lobbying_activities: 1223887

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1223887	53525802-ccf5-4bd7-873a-076533ddf8f2	Q1	INDEPENDENT PHARMACY COOPERATIVE	313098	INDEPENDENT PHARMACY COOPERATIVE	2012	first_quarter	PHA	CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation. S. 1002 SAFE DOSES ACT of 2011. All provisions. Potential prescription drug track-and-trace legislation.	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE		10000	0	0	2012-04-06T13:35:10.240000-04:00